Collegeville, PA, United States of America

Oliver McConnell

This inventor holds 2 USPTO granted patents. Top assignee: Wyeth. Active years: 2009-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oliver McConnell. Retrieved from https://idiyas.com/inventor/oliver-mcconnell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Oliver McConnell: Innovator in Synthetic Metabolites

Introduction

Oliver McConnell is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of synthetic metabolites, holding a total of 2 patents. His work focuses on the development of methods for generating synthetic metabolites of tanaproget derivatives.

Latest Patents

McConnell's latest patents include innovative methods for detecting tanaproget metabolites in samples. The first patent details a method of generating synthetic metabolites of tanaproget derivatives. This invention provides compounds and methods for effectively detecting these metabolites, showcasing McConnell's expertise in the field.

Career Highlights

Oliver McConnell is currently employed at Wyeth, a company known for its commitment to pharmaceutical innovation. His role at Wyeth allows him to further explore and develop his ideas in synthetic metabolites, contributing to advancements in medical research.

Collaborations

Some of McConnell's coworkers include Li Shen and Kelly Keating, who collaborate with him on various projects within the company. Their teamwork enhances the research and development efforts at Wyeth.

Conclusion

In summary, Oliver McConnell is a distinguished inventor whose work in synthetic metabolites has led to valuable patents and advancements in the field. His contributions continue to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…